AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 145 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $271,008 | +50.2% | 64,220 | +10.3% | 0.00% | – |
| Q2 2023 | $180,491 | +122.4% | 58,223 | -0.3% | 0.00% | – |
| Q1 2023 | $81,151 | -26.8% | 58,382 | +4.7% | 0.00% | – |
| Q4 2022 | $110,937 | +19.3% | 55,747 | +20.9% | 0.00% | – |
| Q3 2022 | $93,000 | -21.8% | 46,118 | +23.5% | 0.00% | – |
| Q2 2022 | $119,000 | -20.7% | 37,335 | +3.8% | 0.00% | – |
| Q1 2022 | $150,000 | -25.0% | 35,977 | -13.9% | 0.00% | – |
| Q4 2021 | $200,000 | -2.9% | 41,775 | +8.1% | 0.00% | – |
| Q3 2021 | $206,000 | +23.4% | 38,628 | +18.4% | 0.00% | – |
| Q2 2021 | $167,000 | -18.1% | 32,622 | +7.9% | 0.00% | – |
| Q1 2021 | $204,000 | +88.9% | 30,239 | +27.9% | 0.00% | – |
| Q4 2020 | $108,000 | +66.2% | 23,635 | +40.2% | 0.00% | – |
| Q3 2020 | $65,000 | – | 16,860 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
| Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
| Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
| THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
| GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
| XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
| PA Capital LLC | 33,874 | $132,000 | 0.09% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |